How much is Tenaya Therapeutics worth in 2026?

Tenaya Therapeutics has a current valuation of N/A based on their Later Stage VC (Series C) round and secondary market data.

How much funding has Tenaya Therapeutics raised?

Tenaya Therapeutics has raised N/A in total funding across 1 funding rounds.

Tenaya Therapeutics

Drug Discovery

Tenaya Therapeutics valuation and funding history | Last updated: March 1, 2021 | 1 funding rounds

Current Valuation

N/A

As of March 1, 2021

Total Funding Raised

N/A

Across 1 round

Last Round

Later Stage VC (Series C)

$106.0M

Last Funding

Mar 2021

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
March 1, 2021	Later Stage VC (Series C)	$106.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Tenaya Therapeutics is currently valued at N/A as of March 1, 2021.

Track Tenaya Therapeutics Valuation Updates

Get notified when Tenaya Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Tenaya Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Tenaya Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Tenaya Therapeutics Worth in 2026?

Tenaya Therapeutics is a leading private company in the Drug Discovery sector. Track Tenaya Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Tenaya Therapeutics Valuation is Determined

Private company valuations like Tenaya Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.